3719 Results

People

  1. Hudis
    Hudis
  2. Lee
    Lee
  3. Giralt
    Giralt
  4. Motzer
    Motzer
  5. Barakat
    Barakat
  6. Scher
    Scher
  7. Ladanyi
    Ladanyi
  8. Levine
    Levine
  9. Chi
    Chi
  10. DeMatteo
    DeMatteo

Groups

  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)
  7. Center for Hematologic Malignancies (503)
  8. Department of Pathology and Laboratory Medicine (470)
  9. Population Sciences Research Program (431)
  10. Epidemiology and Biostatistics (426)
  1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II randomized study of cixutumumab (IMC-A12: CIX) or ramucirumab (IMC-1121B: RAM) plus mitoxantrone (M) and prednisone (P) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following disease progression (PD) on docetaxel (DCT) therapy
    Meeting Abstract

    Hussain, M.; Rathkopf, D. E.; Liu, G.; Armstrong, A. J.; Kelly, W. K.; Ferrari, A. C.; Hainsworth, J. D.; Yang, L.; Schwartz, J. D.; Higano, C. S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Alterations in the PI3K/Akt signaling pathway and association with outcome in invasive high-grade urothelial cancer (UC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Al-Ahmadie, H.; Janakiraman, M.; Ostrovnaya, I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Bochner, B.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Exploratory analysis of survival benefit and prior docetaxel (D) treatment in COU-AA-301, a phase III study of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Chi, K. N.; Scher, H. I.; Molina, A.; Logothetis, C.; Jones, R. J.; Staffurth, J.; North, S. A.; Vogelzang, N. J.; Saad, F.; Mainwaring, P. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Systemic therapy for advanced appendiceal adenocarcinoma: An analysis from the National Comprehensive Cancer Network (NCCN) database
    Meeting Abstract

    Tejani, M. A.; ter Veer, A.; Milne, D.; Ottsesen, R.; Bekaii-Saab, T. S.; Benson, A. B.; Schrag, D.; Shibata, S.; Skibber, J. M.; Weiser, M. R.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Examining the management of muscle-invasive bladder cancer (MIBC) by medical oncologists (MO)
    Meeting Abstract

    Apolo, A. B.; Bochner, B.; Steinberg, S. M.; Bajorin, D. F.; Kelly, W. K.; Quinn, D. I.; Vogelzang, N. J.; Sridhar, S. S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Association of single-nucleotide polymorphisms in BCL2L1 and TACC3 with response to bacillus Calmette-Guerin intravesical therapy in non-muscle-invasive bladder cancer
    Meeting Abstract

    Alanee, S.; Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Use of EGF A61G polymorphism to predict overall survival in a phase III study of gemcitabine plus cetuximab versus gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma (SWOG 0205)
    Meeting Abstract

    Labonte, M. J.; Goldman, B. H.; Zhang, W.; Blanke, C. D.; Philip, P. A.; Wong, R.; O'Reilly, E. M.; Benedetti, J. K.; Lenz, H. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The management of patients with T1 adenocarcinoma of the low rectum: An updated decision analysis
    Meeting Abstract

    Johnston, C. F.; Tomlinson, G. A.; Temple, L. K. F.; Baxter, N. N.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I trial of yttrium 90 resin microspheres in the treatment of colon cancer liver metastases progressing despite hepatic arterial as well as systemic chemotherapy: Preliminary results
    Meeting Abstract

    Sofocleous, C. T.; Kemeny, N. E.; Pandit-Taskar, N.; Do, K. G.; Brody, L. A.; Garcia, A. R.; Capanu, M.; Chou, J. F.; Petre, E. N.; Carrasquillo, J. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save